ClinConnect ClinConnect Logo
Search / Trial NCT02885025

Effects of Broccoli Sprout Extract on Allergy Rhinitis

Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Aug 25, 2016

Trial Information

Current as of June 18, 2025

Completed

Keywords

Hypersensitivity Antioxidants

ClinConnect Summary

Allergic rhinitis is a common illness suffered among US Veterans. Despite the availability of medications, many patients fail to get adequate control of symptoms especially in high pollutant areas. Southern California air pollutants, like diesel exhaust particles may act as adjuvants to allergens leading to an exaggerated allergic response in certain individuals. These individuals may lack adequate Glutathione transferase activity; necessary to protect cells against pollutant induced oxidative stress. Sulforaphane has been shown to protect against oxidative stress. The investigators hypothe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion Criteria
  • 1. Females and males 18 years or older.
  • 2. History consistent with seasonal allergic rhinitis consistent with grass allergy (symptoms during summer months, June through August, for at least two consecutive seasons).
  • 3. Not currently taking any medications for allergic rhinitis.
  • 4. Provide written informed consent.
  • 5. Willing and able to comply with all aspects of the protocol.
  • Exclusion Criteria:
  • 1. The subject has any uncontrolled or serious disease, or any medical or surgical or condition that in the opinion of the investigator(s) could affect the subject's safety and/or interfere with the study assessments.
  • 2. History of anaphylaxis to environmental allergens or an unknown trigger.
  • 3. History of broccoli allergy
  • 4. Recent upper respiratory infection (less than 4 weeks prior to study) or other active Infection.
  • 5. Active smoker
  • 6. Currently receiving allergy immunotherapy.
  • 7. History of rhinitis exacerbation within the past 2 weeks.
  • 8. Use of non-selective Beta-Blocker.
  • 9. Inability to give written informed consent.
  • 10. History or evidence of non-stable cognitive capacity within less than 1 year (i.e. Alzheimer's disease, dementia, bipolar disorder) that in the opinion of the investigator(s) could affect the subject's safety and/or interfere with the study assessments.
  • 11. Pregnancy
  • 12. Perennial rhinitis
  • 13. Uncontrolled asthma
  • 14. Forced Expiratory Volume in 1 second \<70% predicted at screening.

About Va Office Of Research And Development

The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.

Locations

West Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

Zhaoping Li, MD

Principal Investigator

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Joseph Stephen Yusin, MD

Principal Investigator

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials